N. ŞAHİN Et Al. , "The Significance of p53 and Estrogen Expression in EndometrialHyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?," CLINICAL ONCOLOGY AND RESEARCH , 2018
ŞAHİN, N. Et Al. 2018. The Significance of p53 and Estrogen Expression in EndometrialHyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?. CLINICAL ONCOLOGY AND RESEARCH .
ŞAHİN, N., AKATLI, A. N., AKPOLAT, N., YILMAZ, E., COŞKUN, E. İ., KARABULUT DOĞAN, Ü., ... ÇOLAK, C.(2018). The Significance of p53 and Estrogen Expression in EndometrialHyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?. CLINICAL ONCOLOGY AND RESEARCH .
ŞAHİN, NURHAN Et Al. "The Significance of p53 and Estrogen Expression in EndometrialHyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?," CLINICAL ONCOLOGY AND RESEARCH , 2018
ŞAHİN, NURHAN Et Al. "The Significance of p53 and Estrogen Expression in EndometrialHyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?." CLINICAL ONCOLOGY AND RESEARCH , 2018
ŞAHİN, N. Et Al. (2018) . "The Significance of p53 and Estrogen Expression in EndometrialHyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?." CLINICAL ONCOLOGY AND RESEARCH .
@article{article, author={NURHAN ŞAHİN Et Al. }, title={The Significance of p53 and Estrogen Expression in EndometrialHyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?}, journal={CLINICAL ONCOLOGY AND RESEARCH}, year=2018}